IART — Integra LifeSciences Holdings

Integra LifeSciences Holdings (IART) is a medical devices company listed on NASDAQ. It is led by Stuart M. Essig Ph.D., based in 1100 Campus Road, Princeton, NJ, United States, 08540, with about 4,427 employees. Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates through Codman Specialty Surgical and Tissue Technologies segments. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment. It also offers after-market services; surgical headlamps and instrumentation; instrument patterns and surgical and lighting products to hospitals, surgery centers, dental, podiatry, and veterinary offices. In addition, the company provides treatment of acute wounds, such as burns; chronic wounds, including diabetic foot ulcers; and surgical tissue repair applications, including hernia reinforcement, tendon protection, and peripheral nerve repair. Further, it offers skin and wound repair, plastics and surgical reconstruction products, and nerve and tendon repair products. Additionally, the company is involved in the ear, nose, and throat business that includes instrumentation, balloon technologies for sinus dilation and eustachian tube dilation, and surgical navigation systems. It offers its products directly through various salesforces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, the Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was formerly known as Integra LifeSciences Corp. and changed its name to Integra LifeSciences Holdings Corporation in June 1995. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.

Latest reported IART revenue for 2025-09-30 was $402.1M. Net income was -$5.4M. Revenue was down 3.3% from 2025-06-30 to 2025-09-30. IART currently screens at market cap $1.32B.

Use this IART page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the IART quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the IART SEC filings page. Lician reads the product cache first so this HTML stays unique to Integra LifeSciences Holdings even when a live quote feed is slow.